Popular stocks:

GameStop

Zomedica

Churchill Capital Corp IV

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: January 26, 2022 12:52

Allogene Therapeutics stock price online today

Analyst Target Price

32.38

Dividend Date

Ex Dividend Date

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2021, 2023, 2024?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $32.38 target price for Allogene Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (22.72 $).

50 Day Moving Average is the resistance level (16.64 $).

Allogene Therapeutics stock monthly Forecast

Date	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
28 Jan 22	11.63	10.98	12.14	10.60 %
29 Jan 22	11.53	11.14	11.72	5.21 %
30 Jan 22	11.24	10.63	11.52	8.29 %
31 Jan 22	11.31	10.94	11.71	7.02 %
01 Feb 22	11.29	10.85	11.46	5.61 %
02 Feb 22	11.47	11.25	11.73	4.21 %
03 Feb 22	11.18	10.67	11.63	8.95 %
04 Feb 22	11.20	11.05	11.42	3.34 %
05 Feb 22	10.51	9.94	10.95	10.21 %
06 Feb 22	10.84	10.24	11.27	10.00 %
07 Feb 22	10.56	10.26	10.74	4.68 %
08 Feb 22	10.97	10.80	11.48	6.26 %
09 Feb 22	11.11	10.60	11.47	8.21 %
10 Feb 22	11.31	11.15	11.62	4.19 %
11 Feb 22	12.10	11.59	12.40	6.94 %
12 Feb 22	11.91	11.35	12.43	9.55 %
13 Feb 22	12.69	12.08	12.98	7.50 %
14 Feb 22	12.87	12.20	13.29	8.93 %
15 Feb 22	12.32	11.73	12.67	8.01 %
16 Feb 22	11.57	11.12	12.10	8.81 %
17 Feb 22	11.91	11.39	12.30	7.98 %
18 Feb 22	11.54	11.07	12.03	8.68 %
19 Feb 22	11.50	10.95	11.87	8.46 %
20 Feb 22	11.88	11.71	12.50	6.74 %
21 Feb 22	11.69	11.44	12.11	5.86 %
22 Feb 22	11.57	11.34	11.86	4.64 %
23 Feb 22	11.79	11.55	12.14	5.07 %
24 Feb 22	11.69	11.25	11.94	6.11 %
25 Feb 22	11.71	11.05	11.89	7.56 %
26 Feb 22	11.32	10.82	11.70	8.13 %

ALLO daily forecast for this month

Allogene Therapeutics stock forecast for 28.01.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.63 Positive intraday dynamics of the instrument is expected with 9.587% volatility is expected.

Pessimistic forecast: 10.98

Optimistic: 12.14

Allogene Therapeutics stock forecast for 29.01.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.53 Negative intraday dynamics of the instrument is expected with 4.956% volatility is expected.

Pessimistic forecast: 11.14

Optimistic: 11.72

Allogene Therapeutics stock forecast for 30.01.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.24 Negative intraday dynamics of the instrument is expected with 7.652% volatility is expected.

Pessimistic forecast: 10.63

Optimistic: 11.52

Allogene Therapeutics stock forecast for 31.01.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.31 Positive intraday dynamics of the instrument is expected with 6.560% volatility is expected.

Pessimistic forecast: 10.94

Optimistic: 11.71

Allogene Therapeutics stock forecast for 01.02.2022.
Estimated Average Forecasted Allogene Therapeutics Price: 11.29 Negative intraday dynamics of the instrument is expected with 5.308% volatility is expected.

Pessimistic forecast: 10.85

Optimistic: 11.46

ALLO Forecast for 2022

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Feb	11.43	10.82	11.90	9.03 %
Mar	11.75	11.36	12.64	10.13 %
Apr	11.67	10.77	12.00	10.30 %
May	12.23	11.44	13.17	13.09 %
Jun	11.05	10.62	11.84	10.27 %
Jul	11.53	10.89	11.83	7.89 %
Aug	11.46	10.95	11.84	7.45 %
Sep	11.41	10.78	12.26	12.01 %
Oct	11.48	10.92	11.86	7.94 %
Nov	11.91	11.66	12.60	7.47 %
Dec	11.83	11.05	12.59	12.22 %

Detailed forecast for 2022

Allogene Therapeutics stock forecast for this year

Allogene Therapeutics share price average forecast for Feb 2022 is: 11.4282 The dynamics are positive.
Allogene Therapeutics share price average forecast for Mar 2022 is: 11.7481 The dynamics are positive.
Allogene Therapeutics share price average forecast for Apr 2022 is: 11.6659 The dynamics are negative.
Allogene Therapeutics share price average forecast for May 2022 is: 12.2259 The dynamics are positive.
Allogene Therapeutics share price average forecast for Jun 2022 is: 11.0522 The dynamics are negative.
Allogene Therapeutics share price average forecast for Jul 2022 is: 11.5274 The dynamics are positive.
Allogene Therapeutics share price average forecast for Aug 2022 is: 11.4583 The dynamics are negative.
Allogene Therapeutics share price average forecast for Sep 2022 is: 11.4124 The dynamics are negative.
Allogene Therapeutics share price average forecast for Oct 2022 is: 11.4809 The dynamics are positive.
Allogene Therapeutics share price average forecast for Nov 2022 is: 11.9057 The dynamics are positive.
Allogene Therapeutics share price average forecast for Dec 2022 is: 11.8343 The dynamics are negative.

Allogene Therapeutics stock Forecast for 2023

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	11.34	10.68	11.98	10.88 %
Feb	12.06	11.24	12.51	10.13 %
Mar	13.00	12.25	13.33	8.10 %
Apr	13.42	13.06	13.69	4.61 %
May	14.21	13.79	15.25	9.60 %
Jun	14.41	13.99	15.53	9.93 %
Jul	15.52	15.09	16.40	8.04 %
Aug	15.69	14.58	16.35	10.84 %
Sep	14.81	13.81	15.12	8.72 %
Oct	14.44	13.52	15.31	11.70 %
Nov	14.70	13.95	15.32	8.92 %
Dec	15.07	14.68	15.43	4.88 %

Detailed forecast for 2023

Allogene Therapeutics stock Forecast for 2024

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	16.14	15.12	16.49	8.32 %
Feb	17.37	15.99	18.29	12.54 %
Mar	18.01	17.50	19.29	9.24 %
Apr	19.32	18.76	19.88	5.64 %
May	19.34	18.61	20.08	7.32 %
Jun	19.40	18.86	20.76	9.16 %
Jul	19.79	18.34	20.72	11.46 %
Aug	20.74	19.20	21.69	11.47 %
Sep	22.81	22.26	23.36	4.69 %
Oct	23.29	22.59	24.71	8.58 %
Nov	22.31	20.93	24.03	12.91 %
Dec	22.63	21.34	24.41	12.60 %

Detailed forecast for 2024

Allogene Therapeutics stock Forecast for 2025

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	23.78	22.80	25.06	9.01 %
Feb	24.52	22.56	26.48	14.81 %
Mar	26.45	24.55	28.04	12.45 %
Apr	28.41	27.64	29.15	5.17 %
May	28.16	26.69	30.10	11.32 %
Jun	27.45	26.46	29.48	10.24 %
Jul	27.56	26.84	28.39	5.44 %
Aug	27.23	26.33	28.32	7.02 %
Sep	25.98	24.44	27.41	10.81 %
Oct	25.98	24.06	27.74	13.30 %
Nov	26.13	24.91	27.26	8.63 %
Dec	26.87	26.30	28.32	7.12 %

Detailed forecast for 2025

Allogene Therapeutics stock Forecast for 2026

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Jan	27.75	26.72	29.28	8.72 %
Feb	26.86	25.47	28.21	9.71 %
Mar	26.92	26.22	27.73	5.44 %
Apr	26.30	25.19	28.40	11.30 %
May	27.38	26.83	29.21	8.15 %
Jun	26.14	25.18	27.92	9.83 %
Jul	26.20	24.57	27.79	11.59 %
Aug	25.54	23.50	26.87	12.55 %
Sep	25.01	23.68	25.73	7.97 %
Oct	24.96	23.91	26.95	11.30 %
Nov	24.33	23.26	25.33	8.17 %
Dec	23.85	22.53	24.56	8.25 %

Detailed forecast for 2026

Allogene Therapeutics overview

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

1 892 612 000 $

EBITDA

-134 911 008

PE Ratio

None

PEG Ratio

None

Dividend Per Share

None

Dividend Yield

EPS

-1.878

Quarterly Earnings Growth YOY

Quarterly Revenue Growth YOY

Trailing PE

Forward PE

EV To Revenue

55.59

EV To EBITDA

52 Week High

39.12

52 Week Low

11.54

50 Day Moving Average

16.64

200 Day Moving Average

22.72

Shares Outstanding

142516000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Other Healthcare sector assets

Name	Symbol	Last Close Price	Change
Abbott Laboratories	ABT	123.82 (24.01.2022)	-1.60 %
AbbVie Inc.	ABBV	131.98 (21.01.2022)	-0.79 %
Aeterna Zentaris Inc.	AEZS	0.3556 (25.01.2022)	3.55 %
Allakos Inc.	ALLK	6.53 (25.01.2022)	-4.11 %
Allogene Therapeutics, Inc.	ALLO	11.36 (25.01.2022)	0.18 %
Amgen Inc.	AMGN	225.04 (25.01.2022)	-0.46 %
Aphria Inc.	APHA	15.38 (07.05.2021)	0.00 %
Atara Biotherapeutics, Inc.	ATRA	15.1 (25.01.2022)	3.00 %
Aurora Cannabis Inc.	ACB	4.21 (25.01.2022)	-2.55 %
Becton Dickinson and Company	BDX	264.63 (21.01.2022)	0.25 %
Biogen Inc.	BIIB	222.31 (25.01.2022)	-1.06 %
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	110.08 (21.01.2022)	-5.10 %
BioNTech SE	BNTX	150.98 (24.01.2022)	2.36 %
bluebird bio, Inc.	BLUE	7.76 (25.01.2022)	0.65 %
Boston Scientific Corp.	BSX	44.86 (14.01.2022)	0.65 %
Bristol-Myers Squibb Company	BMY	62.46 (25.01.2022)	-0.24 %
Canopy Growth Corp.	CGC	7.36 (25.01.2022)	-0.54 %
Castle Biosciences, Inc.	CSTL	34.97 (25.01.2022)	-1.33 %
CLOVER HEALTH INVESTMENTS, CORP	CLOV	3.16 (07.01.2022)	-5.67 %
Eli Lilly and Company	LLY	239.46 (25.01.2022)	-0.40 %
Emergent BioSolutions Inc.	EBS	46.97 (21.01.2022)	0.97 %
Exelixis, Inc.	EXEL	18.21 (25.01.2022)	-1.67 %
G1 Therapeutics, Inc.	GTHX	9.6 (25.01.2022)	6.90 %
Gilead Sciences, Inc.	GILD	68.84 (25.01.2022)	0.39 %
GlaxoSmithKline plc	GSK	44.37 (25.01.2022)	-0.02 %
GoodRx Holdings, Inc.	GDRX	23.95 (25.01.2022)	-1.16 %
GW Pharmaceuticals plc.	GWPH	218.96 (05.05.2021)	0.00 %
Incyte Corp.	INCY	74.15 (25.01.2022)	-1.58 %
Inovio Pharmaceuticals, Inc.	INO	4.04 (25.01.2022)	3.06 %
Johnson & Johnson	JNJ	162.97 (24.01.2022)	-1.15 %
Medtronic plc.	MDT	104.17 (25.01.2022)	-0.04 %
Merck & Co., Inc.	MRK	79.46 (25.01.2022)	0.80 %
Moderna, Inc.	MRNA	152.54 (25.01.2022)	-3.03 %
Novartis AG	NVS	84.54 (25.01.2022)	-0.69 %
Novavax, Inc.	NVAX	77.21 (25.01.2022)	-2.84 %
ObsEva SA	OBSV	1.48 (25.01.2022)	-1.33 %
OrganiGram Holdings Inc.	OGI	1.4 (25.01.2022)	-4.11 %
Pfizer Inc.	PFE	52.54 (25.01.2022)	1.94 %
Regeneron Pharmaceuticals, Inc.	REGN	603.19 (25.01.2022)	-2.94 %
Sanofi	SNY	51.4 (25.01.2022)	1.10 %
Schrodinger, Inc.	SDGR	27.59 (25.01.2022)	-1.36 %
Senseonics Holdings, Inc.	SENS	2.32 (25.01.2022)	-2.52 %
Sorrento Therapeutics, Inc.	SRNE	3.51 (25.01.2022)	-0.71 %
Stryker Corp.	SYK	249.27 (25.01.2022)	-1.05 %
Sundial Growers Inc.	SNDL	0.4764 (25.01.2022)	3.57 %
Teva Pharmaceutical Industries Lim. (TEVA)	TEVA	8.46 (24.01.2022)	-0.59 %
Thermo Fisher Scientific Inc.	TMO	567.75 (25.01.2022)	-1.40 %
Tilray, Inc.	TLRY	5.72 (25.01.2022)	-2.05 %
UnitedHealth Group, Inc.	UNH	462.27 (24.01.2022)	0.24 %
Veeva Systems Inc.	VEEV	221.32 (25.01.2022)	-2.66 %
Zomedica Corp.	ZOM	0.29 (25.01.2022)	-3.33 %
Zynerba Pharmaceuticals, Inc.	ZYNE	2.5 (24.01.2022)	5.49 %

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.